Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2010
05/26/2010CN101711822A Traditional Chinese medicine granules for treating common cold and influenza
05/26/2010CN101711812A Method for preparing oleanolic acid capsule of Chaenomeles speciosa Nakai leaves
05/26/2010CN101711807A Antiphlogistic and antibiotic ointment
05/26/2010CN101711803A Chinese herbal medicine bacteriostatic agent for treating refractory dermatosis and preparation method thereof
05/26/2010CN101711801A Natural galenical preparation for preventing and treating blue-ear disease and hyperpyrexia of unknown origin and preparation method thereof
05/26/2010CN101711799A Externally-applied powder used for midwifery of piglets
05/26/2010CN101711797A Medicine for treating hepatitis B
05/26/2010CN101711796A Application of scullcapflavone in preparing medicament for treating enterovirus infection
05/26/2010CN101711795A Veterinary antipyretic and antiviral medicine composite
05/26/2010CN101711785A Traditional Chinese medicine for treating human papillomavirus infection
05/26/2010CN101711766A Medicine for treating white spots and rotten skin of turtle
05/26/2010CN101711763A Prulifloxacin composition and preparation method thereof, and synthesis method of raw material drugs
05/26/2010CN101711761A Compositions for prevention and treatment of cold and influenza-like symptoms and use methods thereof.
05/26/2010CN101711757A High-efficiency sterilization disinfectant and preparation method thereof
05/26/2010CN101711755A Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
05/26/2010CN101711750A Fluconazole dispersing tablet and preparation method thereof
05/26/2010CN101711748A Method for preparing cefaclor dispersible tablets by dry method direct tablet compressing and cefaclor dispersible tablets prepared by same
05/26/2010CN101711746A Ganciclovir freeze-dry preparation for injection and preparation method thereof
05/26/2010CN101711744A Suspension powder-injection preparation of amoxicillin sodium and flucloxacillin sodium medicinal composition and new application thereof
05/26/2010CN101711740A Method for preparing targeted curcumin nanoparticles for treating ulcerative colitis
05/26/2010CN101283984B Core particle object coated by fungicide and polymer with high biological usage
05/26/2010CN101273991B Applications of tetrahydroindolone/tetrahydroindazolone/tetrahydrocarbazole derivatives and salts thereof in preparation of antiviral medicine
05/26/2010CN101239173B Externally-applied Chinese medicine for treating beriberi
05/26/2010CN101190322B Traditional Chinese medicine for treating zoster post herpetic neuralgia
05/26/2010CN101167942B Medicine for external application
05/26/2010CN101129425B Traditional Chinese medicine for treating zoster
05/26/2010CN101112442B Chinese traditional medicine liniment for treating diseases of furfur and foot tinea
05/26/2010CN101028281B Nano-gel pectin bismuth and its granules medicine
05/26/2010CN101020027B Medicine composition for preventing and treating AIDS and its preparation process and use
05/26/2010CN101015590B Jiawei Fuzheng Jiedu powder for treating chicken renal infectious bronchitis and its preparing process
05/25/2010USRE41356 Hepatitis C inhibitor tri-peptides
05/25/2010US7723524 8-cyanoquinolonecarboxylic acid derivative
05/25/2010US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics
05/25/2010US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723470 Antibiotic of given structure; vancomycin derivatives; enhanced activity, selectivity and reduced mammalian toxicity
05/25/2010US7723467 Antimicrobial compounds
05/25/2010US7723389 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010US7723319 1-[(6-amino-9H-purin-9-yl)methyl]cyclopropyl}oxy)methylphosphonic acid; hepatitis virus
05/25/2010US7723091 combination of a mannanase and a carrier that is adapted for oral administration and does not contain an anti-infection agent other than the mannanase; treating or ameliorating the risk of a digestive tract infection, particularly of Eimeria, Cryptosporidium, or Clostridium
05/25/2010US7723068 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering
05/25/2010US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders
05/25/2010US7722876 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity
05/25/2010CA2493794C Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/25/2010CA2415178C 9-substituted minocycline compounds
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/25/2010CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
05/25/2010CA2375727C Cytofectin dimers and methods of use thereof
05/25/2010CA2354928C Non-mucin type synthetic compounds or it's carrier conjugated compounds
05/25/2010CA2321920C 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
05/25/2010CA2315886C Process for the production of epigallocatechin gallate
05/25/2010CA2199715C Novel implant and novel vector for the treatment of acquired diseases
05/25/2010CA2173130E Glutathione s-transferase-activated compounds
05/20/2010WO2010057141A2 Alphavirus inhibitors and uses thereof
05/20/2010WO2010057101A2 Compounds useful as hiv blockers
05/20/2010WO2010056978A2 System and method for controlling growth of microganisms with brominated furanones
05/20/2010WO2010056927A1 Chitosan derivatives alone or in combination for the treatment of mdr microbial infections
05/20/2010WO2010056896A1 Chitosan derivatives to treat animals or optimize animal health
05/20/2010WO2010056633A2 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
05/20/2010WO2010056216A1 Pharmaceutical composition comprising ibuprofen, pseudoephedrine and chlorpheniramine
05/20/2010WO2010056198A1 Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
05/20/2010WO2010056100A2 Kit of pharmaceutical formulations characterised by the presence of molecular oxygen
05/20/2010WO2010056044A2 Novel compound acting as a vanilloid receptor antagonist, isomer or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same
05/20/2010WO2010055711A1 Peptide composition for saving the life of sirs patient
05/20/2010WO2010055526A1 A novel polymorph of emtricitabine and a process for preparing of the same
05/20/2010WO2010055474A2 Antimicrobial compounds and compositions
05/20/2010WO2010055348A1 [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials
05/20/2010WO2010055340A1 Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer
05/20/2010WO2010055164A2 Novel inhibitors of flavivirus replication
05/20/2010WO2010054858A2 Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens
05/20/2010WO2010054530A1 Method for preparing genetically engineered n-terminal acetylated thymosin alpha 1
05/20/2010WO2010054507A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives
05/20/2010WO2010054482A1 Immunogenic human papillomavirus compositions
05/20/2010WO2010054424A1 Agents and treatment for snoring and respiratory effort related arousals in sleep
05/20/2010WO2010036407A3 Antiviral nucleoside analogs
05/20/2010WO2010032008A3 Dendritic cell modulatory molecule
05/20/2010WO2010030704A3 Antibacterial aminoglycoside analogs
05/20/2010WO2010019489A3 Method for making terpene derivatives
05/20/2010WO2010011315A3 Proteins for use in diagnosing and treating infection and disease
05/20/2010WO2010005836A3 Use of rifalazil to treat colonic disorders
05/20/2010WO2009106073A3 Mhc multimers in borrelia diagnostics and disease
05/20/2010WO2009083663A8 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof
05/20/2010WO2008121634A3 Nucleoside phosphoramidate prodrugs
05/20/2010US20100125101 Immunostimulatory nucleic acid molecules
05/20/2010US20100125094 Pyrrolidinyl modulators of nicotinic acetylcholine receptors
05/20/2010US20100125075 Antibacterial Agents
05/20/2010US20100125074 Thieno-[2,3-d]Pyrimidine and Thieno-Pyridazine Compounds and Methods of Use
05/20/2010US20100125060 Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
05/20/2010US20100125053 Allosteric Modulation of the Dopamine Transporter Protein for the Treatment of HIV-1 Induced Neurologic Dysfunction
05/20/2010US20100124556 Novel shigella protein antigens and methods
05/20/2010US20100124554 Redox-active compounds and related compounds, compositions, methods and systems
05/20/2010US20100124545 Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus
05/20/2010US20100124543 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
05/20/2010US20100124537 Medical applications of alpha-ketoglutarate
05/20/2010CA2743649A1 Agents and treatment for snoring and respiratory effort related arousals in sleep
05/20/2010CA2743624A1 Chitosan derivatives to treat animals or optimize animal health
05/20/2010CA2743591A1 System and method for controlling growth of microganisms with brominated furanones
1 ... 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 ... 1798